IgA nephropathy is a type of kidney disease that is typically treated with various medicines and lifestyle changes. Learn more about IgA nephropathy treatment here.

If you want to contribute to this project, you can do so by forking this repository, finding the addecuate branch and submitting a pull request. You can also submit an issue if you find a bug or want ...

(RTTNews) - Omeros Corporation (OMER) today announced that the FDA has approved YARTEMLEA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy in adults and ...

Omeros has won U.S. Food and Drug Administration approval of its Yartemlea treatment for an often-fatal complication of stem-cell transplants. Omeros on Wednesday said the approval covers Yartemlea ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...

Dublin, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The "Dense Deposit Disease Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, ...

Investment banks manage IPOs, helping with valuation and handling initial trading. In mergers, they offer crucial buy-side and sell-side advisory roles. Since 1999, banks can operate both investment ...

Pete Rathburn is a copy editor and fact-checker with expertise in economics and personal finance and over twenty years of experience in the classroom. Rent stabilization is a form of control over ...

Director of National Intelligence Tulsi Gabbard told Megyn Kelly during an interview this week that there is an ongoing investigation to prove the role U.S.-funded research at the Wuhan Institute of ...

Mirima Freimer, MD, delves into potential reasons behind the longer-term efficacy of zilucoplan and also speaks to the treatment’s safety profile. Freimer was an author on 5 abstracts presented at the ...